West Pharmaceutical Services, Inc. (BVMF:W2ST34)

BVMF:W2ST34 Statistics

Total Valuation

BVMF:W2ST34 has a market cap or net worth of BRL 104.34 billion. The enterprise value is 102.61 billion.

Market Cap	104.34B
Enterprise Value	102.61B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	Nov 11, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.55%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	98.99%
Float	71.45M

Valuation Ratios

The trailing PE ratio is 39.82 and the forward PE ratio is 36.44.

PE Ratio	39.82
Forward PE	36.44
PS Ratio	6.49
PB Ratio	6.42
P/TBV Ratio	6.68
P/FCF Ratio	51.64
P/OCF Ratio	28.22
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.68, with an EV/FCF ratio of 50.79.

EV / Earnings	39.16
EV / Sales	6.42
EV / EBITDA	22.68
EV / EBIT	29.86
EV / FCF	50.79

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.10.

Current Ratio	2.87
Quick Ratio	2.02
Debt / Equity	0.10
Debt / EBITDA	0.36
Debt / FCF	0.80
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.94% and return on invested capital (ROIC) is 12.40%.

Return on Equity (ROE)	16.94%
Return on Assets (ROA)	10.22%
Return on Invested Capital (ROIC)	12.40%
Return on Capital Employed (ROCE)	18.34%
Revenue Per Employee	1.52M
Profits Per Employee	247,214
Employee Count	10,600
Asset Turnover	0.78
Inventory Turnover	4.63

Taxes

In the past 12 months, BVMF:W2ST34 has paid 666.71 million in taxes.

Income Tax	666.71M
Effective Tax Rate	20.28%

Stock Price Statistics

The stock price has decreased by -23.89% in the last 52 weeks. The beta is 1.17, so BVMF:W2ST34's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	-23.89%
50-Day Moving Average	38.35
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.97
Average Volume (20 Days)	118

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.18

Income Statement

In the last 12 months, BVMF:W2ST34 had revenue of BRL 16.08 billion and earned 2.62 billion in profits. Earnings per share was 35.98.

Revenue	16.08B
Gross Profit	5.72B
Operating Income	3.39B
Pretax Income	3.29B
Net Income	2.62B
EBITDA	4.27B
EBIT	3.39B
Earnings Per Share (EPS)	35.98

Balance Sheet

The company has 3.35 billion in cash and 1.61 billion in debt, giving a net cash position of 1.73 billion.

Cash & Cash Equivalents	3.35B
Total Debt	1.61B
Net Cash	1.73B
Net Cash Per Share	n/a
Equity (Book Value)	16.26B
Book Value Per Share	226.18
Working Capital	6.33B

Cash Flow

In the last 12 months, operating cash flow was 3.70 billion and capital expenditures -1.68 billion, giving a free cash flow of 2.02 billion.

Operating Cash Flow	3.70B
Capital Expenditures	-1.68B
Free Cash Flow	2.02B
FCF Per Share	n/a

Margins

Gross margin is 35.58%, with operating and profit margins of 21.08% and 16.29%.

Gross Margin	35.58%
Operating Margin	21.08%
Pretax Margin	20.44%
Profit Margin	16.29%
EBITDA Margin	26.55%
EBIT Margin	21.08%
FCF Margin	12.56%

Dividends & Yields

This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 0.23%.

Dividend Per Share	0.09
Dividend Yield	0.23%
Dividend Growth (YoY)	10.15%
Years of Dividend Growth	1
Payout Ratio	12.34%
Buyback Yield	1.55%
Shareholder Yield	1.78%
Earnings Yield	2.51%
FCF Yield	1.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:W2ST34 has an Altman Z-Score of 13.81 and a Piotroski F-Score of 6.

Altman Z-Score	13.81
Piotroski F-Score	6